Specifically looking into the human epidermal growth factor receptor 2 (HER2)negative breast cancer setting, Joyce A. O’Shaughnessy, M.D., considers what treatment options were historically available for patients.
View more at http://curetoday.com/
CURE: Combining science and humanity to make cancer understandable.